ReviewJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2006
Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy.
Review in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 18 citations in OpenAlex.
- Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease.Frontiers in immunology · 2021Article
- Spatio-temporal expression profile of NGF and the two-receptor system, TrkA and p75NTR, in experimental autoimmune encephalomyelitis.Journal of neuroinflammation · 2020Article
- Neuroinflammation in frontotemporal dementia.Nature reviews. Neurology · 2019Review
- Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein.Proceedings of the National Academy of Sciences of the United States of America · 2016Article
- Article
- Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures.Neural plasticity · 2015Article
- The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype.Journal of neuroinflammation · 2014Article
- The role of cytokines in Guillain-Barré syndrome.Journal of neurology · 2011Review
- Coordinated gene expression of Th17- and Treg-associated molecules correlated with resolution of the monophasic experimental autoimmune uveitis.Molecular vision · 2011Article
- Protective autoimmunity functions by intracranial immunosurveillance to support the mind: The missing link between health and disease.Molecular psychiatry · 2010Article
- Endothelin-1 reduces p-glycoprotein transport activity in an in vitro model of human adult blood-brain barrier.Cellular and molecular neurobiology · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accumulating evidence suggests that neurodegenerative diseases of the central nervous system (CNS) are associated with a local inflammatory response. CNS autoimmune diseases are also associated with inflammation. Does this mean that all neurodegenerative diseases are autoimmune in nature? Does it imply that autoimmune and neurodegenerative diseases are both eligible for the same therapy? What distinguishes between the two types of disease? Do they differ both in etiology and in pathology, or do they have different etiologies but similar pathology and progression? In this minireview we offer a new view of the inflammatory differences between neurodegenerative and autoimmune diseases in the CNS and discuss the implications for therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.